Ignite Creation Date:
2024-05-06 @ 8:08 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02675231
Status:
COMPLETED
Last Update Posted:
2024-03-19
First Post:
2016-02-03
Brief Title:
A Study of Abemaciclib LY2835219 in Women With HR HER2 Locally Advanced or Metastatic Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-03
First Submit QC Date:
February 3 2016
Study First Post Date:
2016-02-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-05-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-18
Last Update Post Date:
2024-03-19
Last Update Post Date Type:
ACTUAL